Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl Nickerson-Nutter

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|January 31, 2009
Reactions of functionalized sulfonamides: application to lowering the lipophilicity of cytosolic phospholipase A2alpha inhibitorsLihren Chen, Weiheng Wang, Katherine L Lee, et al.
Science Translational Medicine|October 29, 2020
Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental modelsSuraj U Hettiarachchi, Yen-Hsing Li, Jyoti Roy, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2006
Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritisYonghan Hu, Neal Green, Lori K Gavrin, et al.
Arthritis and Rheumatism|March 30, 2007
Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritisDeborah A Young, Martin Hegen, Hak Ling Margery Ma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2010
IL-22 induces an acute-phase responseSpencer C Liang, Cheryl Nickerson-Nutter, Debra D Pittman, et al.
EMBO Molecular Medicine|June 30, 2020
Reprogramming of profibrotic macrophages for treatment of bleomycin-induced pulmonary fibrosisFenghua Zhang, Ehab A Ayaub, Bingbing Wang, et al.
Bioorganic & Medicinal Chemistry|August 1, 2007
Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitrilesNeelu Kaila, Neal Green, Huan-Qiu Li, et al.
Arthritis Research & Therapy|June 9, 2019
Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritisYingwen Hu, Bingbing Wang, Jiayin Shen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2012
IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J miceAndrew L Rankin, Heath Guay, Deborah Herber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritisRenoud J Marijnissen, Debbie M Roeleveld, Deborah Young, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|January 31, 2009
Reactions of functionalized sulfonamides: application to lowering the lipophilicity of cytosolic phospholipase A2alpha inhibitorsLihren Chen, Weiheng Wang, Katherine L Lee, et al.
Science Translational Medicine|October 29, 2020
Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental modelsSuraj U Hettiarachchi, Yen-Hsing Li, Jyoti Roy, et al.
Bioorganic & Medicinal Chemistry Letters|September 16, 2006
Inhibition of Tpl2 kinase and TNFalpha production with quinoline-3-carbonitriles for the treatment of rheumatoid arthritisYonghan Hu, Neal Green, Lori K Gavrin, et al.
Arthritis and Rheumatism|March 30, 2007
Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritisDeborah A Young, Martin Hegen, Hak Ling Margery Ma, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2010
IL-22 induces an acute-phase responseSpencer C Liang, Cheryl Nickerson-Nutter, Debra D Pittman, et al.
EMBO Molecular Medicine|June 30, 2020
Reprogramming of profibrotic macrophages for treatment of bleomycin-induced pulmonary fibrosisFenghua Zhang, Ehab A Ayaub, Bingbing Wang, et al.
Bioorganic & Medicinal Chemistry|August 1, 2007
Identification of a novel class of selective Tpl2 kinase inhibitors: 4-Alkylamino-[1,7]naphthyridine-3-carbonitrilesNeelu Kaila, Neal Green, Huan-Qiu Li, et al.
Arthritis Research & Therapy|June 9, 2019
Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritisYingwen Hu, Bingbing Wang, Jiayin Shen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 11, 2012
IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J miceAndrew L Rankin, Heath Guay, Deborah Herber, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2014
Interleukin-21 receptor deficiency increases the initial toll-like receptor 2 response but protects against joint pathology by reducing Th1 and Th17 cells during streptococcal cell wall arthritisRenoud J Marijnissen, Debbie M Roeleveld, Deborah Young, et al.
Pageof 3